Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2

Table 2

Echocardiography results of rats in each group.

Group	N	LVEDd/cm	LVEDs/cm	FS/%	EF/%
Sham-operated	8	0.65 ± 0.104*	0.37 ± 0.128*	43.92 ± 9.048*	81.52 ± 5.968*
Model	8	0.95 ± 0.104^▲	0.77 ± 0.134^▲	25.33 ± 11.176^▲	41.55 ± 14.371^▲
Fosinopril sodium	8	0.89 ± 0.140^▲	0.70 ± 0.133^▲	24.20 ± 9.285	50.98 ± 9.094^▲*
QSYQ	8	0.74 ± 0.130^▲*	0.55 ± 0.141^▲*	29.71 ± 9.993^▲	57.18 ± 11.678^▲*

^▲P < 0. 05, versus sham-operated group; *P < 0.05, versus model group.